Geron Corp (NASDAQ: GERN) is -25.71% lower on its value in year-to-date trading and has touched a low of $1.64 and a high of $5.34 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GERN stock was last observed hovering at around $2.56 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $2.63, the stock is -8.68% and -19.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 18.0 million and changing 2.73% at the moment leaves the stock -34.83% off its SMA200. GERN registered 27.05% gain for a year compared to 6-month loss of -41.03%.
The stock witnessed a -9.93% gain in the last 1 month and extending the period to 3 months gives it a -32.04%, and is -6.74% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.96% over the week and 5.13% over the month.
Geron Corp (GERN) has around 141 employees, a market worth around $1.59B and $29.48M in sales. Profit margin for the company is -682.48%. Distance from 52-week low is 60.37% and -50.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.53%).
with sales reaching $45.29M over the same period.The EPS is expected to grow by 21.15% this year, but quarterly earnings will post 31,348.00% year-over-year. Quarterly sales are estimated to grow 196,802.17% in year-over-year returns.
Geron Corp (GERN) Top Institutional Holders
The shares outstanding are 603.10M, and float is at 555.32M with Short Float at 13.43%.
The top institutional shareholder in the company is BLACKROCK INC. with over 46.55 million shares valued at $197.38 million. The investor’s holdings represent 7.7138% of the GERN Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 46.2 million shares valued at $195.9 million to account for 7.0656 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 31.93 million shares representing 5.2914% and valued at over $135.4 million, while VIVO CAPITAL, LLC holds 4.5113 of the shares totaling 27.23 million with a market value of $115.44 million.
Geron Corp (GERN) Insider Activity
The most recent transaction is an insider sale by GRETHLEIN ANDREW J, the company’s EVP, Chief Operating Officer. SEC filings show that GRETHLEIN ANDREW J sold 674,348 shares of the company’s common stock on Jul 08 ’24 at a price of $4.56 per share for a total of $3.07 million. Following the sale, the insider now owns 0.0 shares.
Geron Corp disclosed in a document filed with the SEC on Jun 10 ’24 that Feller Faye (EVP, Chief Medical Officer) sold a total of 287,900 shares of the company’s common stock. The trade occurred on Jun 10 ’24 and was made at $4.63 per share for $1.33 million. Following the transaction, the insider now directly holds 0.0 shares of the GERN stock.
Still, SEC filings show that on Jun 10 ’24, Kapur Anil (EVP, Corp Strategy & CCO) disposed off 421,875 shares at an average price of $4.64 for $1.96 million. The insider now directly holds 0 shares of Geron Corp (GERN).
